GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $742,000 | -0.9% | 17,036 | -1.0% | 0.08% | +15.3% |
| Q1 2022 | $749,000 | +0.8% | 17,206 | +2.1% | 0.07% | +2.9% |
| Q4 2021 | $743,000 | +208.3% | 16,846 | +178.7% | 0.07% | +169.2% |
| Q3 2021 | $241,000 | 0.0% | 6,044 | 0.0% | 0.03% | 0.0% |
| Q2 2021 | $241,000 | +45.2% | 6,044 | +36.4% | 0.03% | +18.2% |
| Q3 2020 | $166,000 | -63.4% | 4,432 | -60.2% | 0.02% | -67.2% |
| Q2 2020 | $453,000 | +223.6% | 11,122 | +200.8% | 0.07% | +139.3% |
| Q1 2020 | $140,000 | +18.6% | 3,698 | +47.7% | 0.03% | +33.3% |
| Q4 2019 | $118,000 | +10.3% | 2,504 | -0.8% | 0.02% | 0.0% |
| Q3 2019 | $107,000 | -21.9% | 2,525 | -26.3% | 0.02% | -25.0% |
| Q2 2019 | $137,000 | +22.3% | 3,428 | +27.6% | 0.03% | +21.7% |
| Q1 2019 | $112,000 | +1.8% | 2,686 | -7.3% | 0.02% | -14.8% |
| Q4 2018 | $110,000 | -78.1% | 2,898 | -76.9% | 0.03% | -71.0% |
| Q3 2018 | $503,000 | -1.6% | 12,568 | -0.9% | 0.09% | -8.8% |
| Q2 2018 | $511,000 | – | 12,686 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |